Sampre Nutritions Limited Share Price

Equities

SAMPRE6

INE375C01014

Food Processing

Market Closed - Bombay S.E. 11:00:53 03/05/2024 BST 5-day change 1st Jan Change
70.19 INR -0.06% Intraday chart for Sampre Nutritions Limited +0.26% -7.07%

Financials

Sales 2022 231M 2.77M 221M Sales 2023 371M 4.45M 354M Capitalization 814M 9.76M 778M
Net income 2022 3M 35.96K 2.87M Net income 2023 3M 35.96K 2.87M EV / Sales 2022 1.59 x
Net Debt 2022 212M 2.54M 202M Net Debt 2023 166M 2M 159M EV / Sales 2023 2.64 x
P/E ratio 2022
51 x
P/E ratio 2023
247 x
Employees 128
Yield 2022 *
-
Yield 2023
-
Free-Float 35.07%
More Fundamentals * Assessed data
Dynamic Chart
Sampre Nutritions Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Sampre Nutritions Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Sampre Nutritions Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Sampre Nutritions Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Sampre Nutritions Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Sampre Nutritions Limited Announces Appointment of Mrs. Krishnama Nupur as Company Secretary and Compliance Officer CI
Sampre Nutritions Limited Announces Resignation of Deepak Bissa as Company Secretary and Compliance Officer CI
Sampre Nutritions Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Sampre Nutritions Limited Approves Proposal of Setting Up of Wholly Owned Subsidiary in Silicon Oasis Free Zone, Dubai, United Arab Emirates CI
Sampre Nutritions Limited announced that it has received INR 97.2 million in funding from Foresight Holdings Private Limited, Delta Infragalaxy LLP, and other investors CI
Sampre Nutritions Limited Enters into Memorandum of Understanding and Protocol of Agreement with the African Peace and Security Union for Setting Up of Manufacturing Plant for Manufacture of Fortified Vitaminized Nutri Candy CI
Sampre Nutritions Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Sampre Nutritions Limited announced that it expects to receive INR 135 million in funding from Foresight Holdings Private Limited, Delta Infragalaxy LLP CI
Sampre Nutritions to Consider Issuance of Shares or Convertible Warrants MT
Sampre Nutritions Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
More news
1 day-0.06%
1 week+0.26%
Current month-3.12%
1 month-0.44%
3 months-13.35%
6 months+19.78%
Current year-7.07%
More quotes
1 week
67.10
Extreme 67.1
74.50
1 month
67.10
Extreme 67.1
77.45
Current year
57.20
Extreme 57.2
99.33
1 year
46.55
Extreme 46.55
99.33
3 years
13.90
Extreme 13.9
296.35
5 years
7.51
Extreme 7.51
296.35
10 years
7.51
Extreme 7.51
296.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 -
Director of Finance/CFO - 30/04/11
Compliance Officer - 01/05/23
Members of the board TitleAgeSince
Director/Board Member 68 31/05/06
Chief Executive Officer 70 -
Director/Board Member 61 26/09/14
More insiders
Date Price Change Volume
03/05/24 70.19 -0.06% 4,672
02/05/24 70.23 -3.06% 6,333
30/04/24 72.45 +1.87% 42,167
29/04/24 71.12 +1.59% 11,809
26/04/24 70.01 -0.60% 19,894

Delayed Quote Bombay S.E., May 03, 2024 at 11:00 am

More quotes
Sampre Nutritions Limited is an India-based company, which is engaged in manufacturing of sugar candies. The Company operates through manufacturing and sale of sugar boiled candies and toffees segment. The Company offers confectionery, eclairs, candies, toffees, powder and center filled products. The Company is primarily engaged in manufacturing of eclairs for domestic and export market. The Company has two manufacturing facilities, including of leasehold unit.
More about the company
  1. Stock Market
  2. Equities
  3. SAMPRE6 Stock